Shenzhen Weiguang Biological Products Co Ltd (002880) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.022x

Based on the latest financial reports, Shenzhen Weiguang Biological Products Co Ltd (002880) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥51.60 Million ≈ $7.55 Million USD) by net assets (CN¥2.36 Billion ≈ $344.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shenzhen Weiguang Biological Products Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Shenzhen Weiguang Biological Products Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002880 current and long-term liabilities for a breakdown of total debt and financial obligations.

Shenzhen Weiguang Biological Products Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Weiguang Biological Products Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shinkong Synthetic Fiber Corp TW:1409	-0.061x
Yatharth Hospital & Trauma Care Services Limited NSE:YATHARTH	0.006x
M Grass Ecology and Environment Group Co Ltd SHE:300355	0.115x
Theravance Biopharma Inc NASDAQ:TBPH	-0.020x
Tsakos Energy Navigation Ltd NYSE:TEN	0.046x
Ratos AB (publ) ST:RATO-B	0.042x
Chongqing Pharscin Pharmaceutical Co Ltd SHE:002907	0.000x
Omada Health, Inc. Common Stock NASDAQ:OMDA	0.047x

Annual Cash Flow Conversion Efficiency for Shenzhen Weiguang Biological Products Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Shenzhen Weiguang Biological Products Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Shenzhen Weiguang Biological Products Co market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.24 Billion ≈ $328.40 Million	CN¥177.77 Million ≈ $26.01 Million	0.079x	-59.28%
2023-12-31	CN¥2.05 Billion ≈ $299.34 Million	CN¥397.94 Million ≈ $58.23 Million	0.195x	+30198.49%
2022-12-31	CN¥1.87 Billion ≈ $273.28 Million	CN¥1.20 Million ≈ $175.46K	0.001x	-99.53%
2021-12-31	CN¥1.79 Billion ≈ $261.68 Million	CN¥246.89 Million ≈ $36.13 Million	0.138x	-26.25%
2020-12-31	CN¥1.62 Billion ≈ $237.61 Million	CN¥303.96 Million ≈ $44.48 Million	0.187x	+46.04%
2019-12-31	CN¥1.45 Billion ≈ $212.00 Million	CN¥185.70 Million ≈ $27.17 Million	0.128x	+68.15%
2018-12-31	CN¥1.31 Billion ≈ $191.08 Million	CN¥99.54 Million ≈ $14.57 Million	0.076x	+220.52%
2017-12-31	CN¥1.20 Billion ≈ $176.06 Million	CN¥28.61 Million ≈ $4.19 Million	0.024x	-90.47%
2016-12-31	CN¥506.44 Million ≈ $74.11 Million	CN¥126.41 Million ≈ $18.50 Million	0.250x	-34.53%
2015-12-31	CN¥393.71 Million ≈ $57.61 Million	CN¥150.09 Million ≈ $21.96 Million	0.381x	-12.24%
2014-12-31	CN¥308.86 Million ≈ $45.20 Million	CN¥134.17 Million ≈ $19.63 Million	0.434x	+364.69%
2013-12-31	CN¥223.88 Million ≈ $32.76 Million	CN¥20.93 Million ≈ $3.06 Million	0.093x	-89.11%
2012-12-31	CN¥135.00 Million ≈ $19.76 Million	CN¥115.88 Million ≈ $16.96 Million	0.858x	--

About Shenzhen Weiguang Biological Products Co Ltd

SHE:002880 China Biotechnology

Market Cap

$853.26 Million

CN¥5.83 Billion CNY

Market Cap Rank

#9838 Global

#2782 in China

Share Price

CN¥25.71

Change (1 day)

-0.12%

52-Week Range

CN¥25.31 - CN¥31.04

All Time High

CN¥963796.17